502 related articles for article (PubMed ID: 12438034)
1. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents.
Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA
AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034
[TBL] [Abstract][Full Text] [Related]
2. [Magnetic resonance imaging of hepatic focal lesions: dynamic contrastographic evaluation with gadolinium versus reticulo-endothelial hepato-specific contrast media].
Di Cesare E; Cariello G; Barile A; Sabatini M; Michelini O; Erriquez D; Masciocchi C
Radiol Med; 2000 Oct; 100(4):245-50. PubMed ID: 11155451
[TBL] [Abstract][Full Text] [Related]
3. Characterization of focal hepatic lesions with ferumoxides-enhanced T2-weighted MR imaging.
Paley MR; Mergo PJ; Torres GM; Ros PR
AJR Am J Roentgenol; 2000 Jul; 175(1):159-63. PubMed ID: 10882267
[TBL] [Abstract][Full Text] [Related]
4. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
5. Detection and characterization of focal hepatic lesions: mangafodipir vs. superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Kim MJ; Kim JH; Lim JS; Oh YT; Chung JJ; Choi JS; Lee WJ; Kim KW
J Magn Reson Imaging; 2004 Oct; 20(4):612-21. PubMed ID: 15390224
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
[TBL] [Abstract][Full Text] [Related]
7. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
[TBL] [Abstract][Full Text] [Related]
8. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison.
Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A
J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270
[TBL] [Abstract][Full Text] [Related]
9. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging of the liver: what kind of contrast agents?].
De Gaspari A; De Cobelli F; Del Maschio A
Radiol Med; 2001 Sep; 102(3):109-21. PubMed ID: 11677451
[TBL] [Abstract][Full Text] [Related]
11. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
[TBL] [Abstract][Full Text] [Related]
12. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
Kim SK; Kim SH; Lee WJ; Kim H; Seo JW; Choi D; Lim HK; Lee SJ; Lim JH
AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056
[TBL] [Abstract][Full Text] [Related]
13. Focal nodular hyperplasia: lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study.
Terkivatan T; van den Bos IC; Hussain SM; Wielopolski PA; de Man RA; IJzermans JN
J Magn Reson Imaging; 2006 Oct; 24(4):864-72. PubMed ID: 16947339
[TBL] [Abstract][Full Text] [Related]
14. Telangiectatic focal nodular hyperplasia: US, CT, and MR imaging findings with histopathologic correlation in 13 cases.
Attal P; Vilgrain V; Brancatelli G; Paradis V; Terris B; Belghiti J; Taouli B; Menu Y
Radiology; 2003 Aug; 228(2):465-72. PubMed ID: 12819340
[TBL] [Abstract][Full Text] [Related]
15. Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions.
Vogl TJ; Hammerstingl R; Schwarz W; Mack MG; Müller PK; Pegios W; Keck H; Eibl-Eibesfeldt A; Hoelzl J; Woessmer B; Bergman C; Felix R
Radiology; 1996 Mar; 198(3):881-7. PubMed ID: 8628887
[TBL] [Abstract][Full Text] [Related]
16. Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences.
Precetti-Morel S; Bellin MF; Ghebontni L; Zaïm S; Opolon P; Poynard T; Mathurin P; Cluzel P
Eur Radiol; 1999; 9(8):1535-42. PubMed ID: 10525860
[TBL] [Abstract][Full Text] [Related]
17. Multifocal inflammatory pseudotumor of the liver: dynamic gadolinium-enhanced, ferumoxides-enhanced, and mangafodipir trisodium-enhanced MR imaging findings.
Mortelé KJ; Wiesner W; de Hemptinne B; Elewaut A; Praet M; Ros PR
Eur Radiol; 2002 Feb; 12(2):304-8. PubMed ID: 11870426
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging.
Takahama K; Amano Y; Hayashi H; Ishihara M; Kumazaki T
Abdom Imaging; 2003; 28(4):525-30. PubMed ID: 14580096
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of focal nodular hyperplasia of the liver: value of contrast-enhanced dynamic study.
Irie H; Honda H; Kaneko K; Kuroiwa T; Fukuya T; Yoshimitsu K; Ono M; Kawanami T; Yoshida M; Maeda T; Masuda K
Radiat Med; 1997; 15(1):29-35. PubMed ID: 9134582
[TBL] [Abstract][Full Text] [Related]
20. Comparison of mangafodipir trisodium- and ferucarbotran-enhanced MRI for detection and characterization of hepatic metastases in colorectal cancer patients.
Kim HJ; Kim KW; Byun JH; Won HJ; Shin YM; Kim PN; Lee MS; Lee MG
AJR Am J Roentgenol; 2006 Apr; 186(4):1059-66. PubMed ID: 16554579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
